Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease.
D003902:Detergents / Q000494:pharmacology; D005060:Europe / Q000208:ethnology; D005776:Gaucher Disease / Q000175:diagnosis / Q000201:enzymology*; D005959:Glucosidases / Q000378:metabolism*; D005960:Glucosides / Q000494:pharmacology; D006801:Humans; D006868:Hydrolysis; D007294:Inositol / Q000031:analogs & derivatives / Q000494:pharmacology; D007585:Jews; D011609:Psychosine / Q000031:analogs & derivatives / Q000494:pharmacology; D001617:beta-Glucosidase / Q000037:antagonists & inhibitors / Q000378:metabolism*
D003902:Detergents; D005960:Glucosides; D011609:Psychosine; C018619:octyl-beta-D-glucoside; D007294:Inositol; C035742:sphingosyl beta-glucoside; D005959:Glucosidases; D001617:beta-Glucosidase; C011423:conduritol epoxide